NCT02760199View on ClinicalTrials.gov

89Zr-AMG211 PET Imaging Study

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 3, 2017

Study Completion Date

May 3, 2017

Conditions
Advanced Gastrointestinal Cancer
Interventions
DRUG

89Zr-AMG211

Injection of 89Zr-AMG211 for imaging.

DEVICE

89-ZrAMG211 PET

89Zr-AMG211 PET scan(s).

Trial Locations (2)

1081 HV

VUmc, Amsterdam

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02760199 - 89Zr-AMG211 PET Imaging Study | Biotech Hunter | Biotech Hunter